Deficiency in Homologous Recombination Renders Mammalian Cells More Sensitive to Proton Versus Photon Irradiation
Creators
- 1. Laboratory for Molecular Radiobiology, University Hospital Zurich, Zurich (Switzerland)
- 2. Center for Proton Therapy, Paul Scherrer Institute, Villigen (Switzerland)
- 3. Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (United States)
- 4. Institute of Molecular Cancer Research, University of Zurich, Zurich (Switzerland)
Description
Purpose: To investigate the impact of the 2 major DNA repair machineries on cellular survival in response to irradiation with the 2 types of ionizing radiation. Methods and Materials: The DNA repair and cell survival endpoints in wild-type, homologous recombination (HR)-deficient, and nonhomologous end-joining-deficient cells were analyzed after irradiation with clinically relevant, low-linear energy transfer (LET) protons and 200-keV photons. Results: All cell lines were more sensitive to proton irradiation compared with photon irradiation, despite no differences in the induction of DNA breaks. Interestingly, HR-deficient cells and wild-type cells with small interfering RNA-down-regulated Rad51 were markedly hypersensitive to proton irradiation, resulting in an increased relative biological effectiveness in comparison with the relative biological effectiveness determined in wild-type cells. In contrast, lack of nonhomologous end-joining did not result in hypersensitivity toward proton irradiation. Repair kinetics of DNA damage in wild-type cells were equal after both types of irradiation, although proton irradiation resulted in more lethal chromosomal aberrations. Finally, repair kinetics in HR-deficient cells were significantly delayed after proton irradiation, with elevated amounts of residual γH2AX foci after irradiation. Conclusion: Our data indicate a differential quality of DNA damage by proton versus photon irradiation, with a specific requirement for homologous recombination for DNA repair and enhanced cell survival. This has potential relevance for clinical stratification of patients carrying mutations in the DNA damage response pathways
Availability note (English)
Available from http://dx.doi.org/10.1016/j.ijrobp.2013.09.041Additional details
Identifiers
- DOI
- 10.1016/j.ijrobp.2013.09.041;
- PII
- S0360-3016(13)03181-7;
Publishing Information
- Journal Title
- International Journal of Radiation Oncology, Biology and Physics
- Journal Volume
- 88
- Journal Issue
- 1
- Journal Page Range
- p. 175-181
- ISSN
- 0360-3016
- CODEN
- IOBPD3
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 45104721
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- CHROMOSOMAL ABERRATIONS; DNA DAMAGES; DNA REPAIR; IRRADIATION; KEV RANGE 100-1000; PROTON BEAMS; RADIOTHERAPY; RBE
- Descriptors DEC
- BEAMS; BIOLOGICAL RECOVERY; BIOLOGICAL REPAIR; ENERGY RANGE; KEV RANGE; MEDICINE; MUTATIONS; NUCLEAR MEDICINE; NUCLEON BEAMS; PARTICLE BEAMS; RADIOLOGY; REPAIR; THERAPY
Optional Information
- Copyright
- Copyright (c) 2014 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.